Autonomix Medical closes $11.2M IPO, regains cardiology rights via $8M warrant deal

Autonomix Medical, Inc.

IPO closed Jan 26: 2,234,222 shares at $5.00, gross proceeds $11,171,110 before expenses.
Regained exclusive worldwide cardiology rights from Impulse Medical in exchange for warrant to buy 1.6M shares at $0.001 per share.
CEO Lori Bisson cites momentum and on-track first-in-human pancreatic cancer pain study this quarter.
Warrant shares subject to lockup: 12.5% for 6 months, remainder for 12 months post-IPO.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.